Biotech Cities: A Conversation With Alexandria CEO Joel Marcus
This article was originally published in Start Up
Executive Summary
Alexandria Real Estate Equities is the largest life science landlord in the US, but it also has a five-member venture team and more than 300 investments on its ledger, mainly in biotherapeutics. Alexandria CEO Joel Marcus discusses the firm's hush-hush portfolio and the evolution of life science workplaces.
You may also be interested in...
Bayer Establishes Workspace For Start-Ups In An Innovative Move
One year after opening its Innovation Center in Mission Bay, Calif., Bayer is opening the space to start-ups to help establish their research labs.
AAVLife: Another Gene Therapy Effort To Treat Friedreich's Ataxia
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.
With AAVLife Debut, Another Gene Therapy Effort To Treat Friedreich's Ataxia
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.